Skip to main content

Ahmed Nadim

In the past year, 3 open-market sale filings worth $518.0K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$518.0K
3 filings
Net
−$518.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Ahmed Nadim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

CGEM Cullinan Therapeutics, Inc.

President and CEO11 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 25, 2026 (view filing)Feb 241 dayAhmed NadimPresident and CEOSSale−13.5K$14.47−$195.6K−3.3%390.8K after
Feb 23, 2026 (view filing)Feb 203 daysAhmed NadimPresident and CEOSSale−16.4K$13.62−$223.1K−3.9%404.3K after
Dec 29, 2025 (view filing)Dec 236 daysAhmed NadimPresident and CEOSSale−9.92K$10.01−$99.3K−2.3%420.7K after
Feb 27, 2025 (view filing)Feb 252 daysAhmed NadimPresident and CEOSSale−12.5K$8.53−$106.9K−2.8%430.6K after
Dec 27, 2024 (view filing)Dec 243 daysAhmed NadimPresident and CEOSSale−8.40K$11.87−$99.7K−3.1%263.1K after
Dec 27, 2023 (view filing)Dec 261 dayAhmed NadimPresident and CEOSSale−4.27K$9.24−$39.5K−3.7%111.5K after
Jun 29, 2023 (view filing)Jun 281 dayAhmed NadimPresident and CEOSSale−759$11.40−$8.65K−0.7%115.8K after
May 24, 2023 (view filing)May 231 dayAhmed NadimPresident and CEOSSale−707$9.15−$6.47K−0.6%116.6K after
Apr 26, 2023 (view filing)Apr 251 dayAhmed NadimPresident and CEOSSale−716$10.59−$7.58K−0.6%117.3K after
Mar 27, 2023 (view filing)Mar 234 daysAhmed NadimPresident and CEOSSale−706$10.51−$7.42K−0.6%118.0K after

See all 11 trades at CGEM